Skip Navigation


Human Molecular Genetics Advance Access originally published online on November 29, 2007
Human Molecular Genetics 2008 17(6):800-805; doi:10.1093/hmg/ddm351
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/6/800    most recent
ddm351v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bethke, L.
Right arrow Articles by Houlston, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bethke, L.
Right arrow Articles by Houlston, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma

Lara Bethke1, Emily Webb1, Anne Murray1, Minouk Schoemaker2, Christoffer Johansen3, Helle Collatz Christensen3, Kenneth Muir4, Patricia McKinney5, Sarah Hepworth5, Polyxeni Dimitropoulou4, Artitaya Lophatananon4, Maria Feychting6, Stefan Lönn7, Anders Ahlbom6, Beatrice Malmer8, Roger Henriksson8, Anssi Auvinen9,10, Anne Kiuru10, Tiina Salminen9,10, Anthony Swerdlow2 and Richard Houlston1,*

1 Section of Cancer Genetics 2 Section of Epidemiology, Institute of Cancer Research, 15 Cotswold Rd, Sutton, Surrey SM2 5NG, UK 3 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark 4 Division of Epidemiology and Public Health, University of Nottingham Medical School Queen’s Medical Centre, Nottingham, UK 5 Centre for Epidemiology and Biostatistics, University of Leeds, UK 6 Division of Epidemiology, Institute of Environmental Medicine 7 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden 8 Department of Radiation Sciences, Oncology Umeå University, Sweden 9 Department of Epidemiology, Tampere School of Public Health, University of Tampere, Finland 10 Department of Research and Environmental Surveillance, Radiation and Nuclear Safety Authority, STUK, Helsinki, Finland

* To whom correspondence should be addressed. Tel: +44 2087224175; Fax: +44 2087224059; Email: richard.houlston{at}icr.ac.uk

Received October 16, 2007; Accepted November 28, 2007

Much of the variation in inherited risk of glioma is likely to be explained by combinations of common low risk variants. The established relationship between glioma risk and exposure to ionizing radiation led us to examine whether variants in the DNA repair genes contribute to disease susceptibility. We evaluated 1127 haplotype-tagging single-nucleotide polymorphisms (SNPs) supplemented with 388 putative functional SNPs to capture most of the common variation in 136 DNA repair genes, in five unique case–control series from four different countries (1013 cases, 1016 controls). We identified 16 SNPs associated with glioma risk at the 1% significance level. The highest association observed across the five independent case–control datasets involved rs243356, which maps to intron 3 of CHAF1A (trend odds ratio, 1.32; 95% confidence interval 1.14–1.54; P = 0.0002; false-positive report probability = 0.055, based on a prior probability of 0.01). Our results provide additional support for the hypothesis that low penetrance variants contribute to the risk of developing glioma and suggest that a genetic variant located in or around the CHAF1A gene contributes to disease risk.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. S. Chang, R.-F. Yeh, J. K. Wiencke, J. L. Wiemels, I. Smirnov, A. R. Pico, T. Tihan, J. Patoka, R. Miike, J. D. Sison, et al.
Pathway Analysis of Single-Nucleotide Polymorphisms Potentially Associated with Glioblastoma Multiforme Susceptibility Using Random Forests
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1368 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. M. Dong, J. D. Potter, E. White, C. M. Ulrich, L. R. Cardon, and U. Peters
Genetic Susceptibility to Cancer: The Role of Polymorphisms in Candidate Genes
JAMA, May 28, 2008; 299(20): 2423 - 2436.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.